0000950103-20-003118.txt : 20200221
0000950103-20-003118.hdr.sgml : 20200221
20200221175435
ACCESSION NUMBER: 0000950103-20-003118
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200219
FILED AS OF DATE: 20200221
DATE AS OF CHANGE: 20200221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sumitomo Chemical Co., Ltd.
CENTRAL INDEX KEY: 0001798550
STATE OF INCORPORATION: M0
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38667
FILM NUMBER: 20641407
BUSINESS ADDRESS:
STREET 1: 27-1, SHINKAWA 2-CHOME
STREET 2: CHUO-KU
CITY: TOKYO
STATE: M0
ZIP: 104-8260
BUSINESS PHONE: 813-5543-5142
MAIL ADDRESS:
STREET 1: 27-1, SHINKAWA 2-CHOME
STREET 2: CHUO-KU
CITY: TOKYO
STATE: M0
ZIP: 104-8260
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dainippon Sumitomo Pharma Co Ltd
CENTRAL INDEX KEY: 0001446601
STATE OF INCORPORATION: M0
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38667
FILM NUMBER: 20641408
BUSINESS ADDRESS:
STREET 1: 60 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-319-7600
MAIL ADDRESS:
STREET 1: 60 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sumitovant Biopharma Ltd.
CENTRAL INDEX KEY: 0001798244
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38667
FILM NUMBER: 20641409
BUSINESS ADDRESS:
STREET 1: SUITE 1, 3RD FLOOR
STREET 2: 11-12 ST. JAMES SQUARE
CITY: LONDON
STATE: X0
ZIP: SW1Y 4LB
BUSINESS PHONE: (646) 802-3660
MAIL ADDRESS:
STREET 1: C/O ROIVANT SCIENCES, INC.
STREET 2: 320 WEST 37TH STREET, 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Urovant Sciences Ltd.
CENTRAL INDEX KEY: 0001740547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 5281 CALIFORNIA AVENUE
STREET 2: SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
BUSINESS PHONE: 949-226-6029
MAIL ADDRESS:
STREET 1: 5281 CALIFORNIA AVENUE
STREET 2: SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
4
1
dp121731_4-sumitomo.xml
X0306
4
2020-02-19
0
0001740547
Urovant Sciences Ltd.
UROV
0001798550
Sumitomo Chemical Co., Ltd.
27-1, SHINKAWA 2-CHOME
CHUO-KU
TOKYO
M0
104-8260
JAPAN
0
0
0
1
See Footnote (1)
0001446601
Dainippon Sumitomo Pharma Co Ltd
6-8 DOSHOMACHI 2-CHOME
CHUO-KU
OSAKA
M0
541-0045
JAPAN
0
0
0
1
See Footnote (1)
0001798244
Sumitovant Biopharma Ltd.
11-12 ST. JAMES'S SQUARE SUITE 1
3RD FLOOR
LONDON
X0
SW1Y 4LB
UNITED KINGDOM
0
0
1
0
Common Stock
2020-02-19
4
P
0
12873
13.08
A
22872886
I
See Footnote
Common Stock
2020-02-19
4
P
0
15165
13.08
A
22888051
I
See Footnote
Common Stock
2020-02-19
4
P
0
75212
13.08
A
22963263
I
See Footnote
Sumitovant Biopharma Ltd. ("Sumitovant") directly owns 22,963,263 shares of Common Stock. Sumitovant is a wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon"), which is a 51.76% owned subsidiary of Sumitomo Chemical Co., Ltd. ("Sumitomo Chemical"). Sumitomo Dainippon and Sumitomo Chemical may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended) the reported securities that Sumitovant owns. Each of Sumitomo Dainippon and Sumitomo Chemical disclaims beneficial ownership of such reported securities except to the extent of their pecuniary interest therein.
Sumitomo Chemical Co., Ltd. By: Yoshiaki Oda, Managing Executive /s/ Yoshiaki Oda
2020-02-21
Sumitomo Dainippon Pharma Co., Ltd. By: Yumi Sato, Senior /s/ Yumi Sato
2020-02-21
Sumitovant Biopharma Ltd. By: Marianne L. Romeo, Authorized /s/ Marianne L. Romeo
2020-02-21